Weight Loss Drugs Belviq and Belviq XR Connected to Cancer and Force Recall
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) claims that a safety trial for the weight-loss drug lorcaserin, sold by the brand name Belviq and Belviq XR, proved that taking the drug increases the risk of developing cancer. As a result of the FDA’s interpretation of the trial results, Eisai, the maker of Belviq, … [Read more...] about Weight Loss Drugs Belviq and Belviq XR Connected to Cancer and Force Recall
FDA Asks for Withdrawal of Belviq After Finding Cancer Link
WASHINGTON, D.C. — Prescription drug manufacturer Eisai will pull its weight-loss drug Belviq from circulation after the U.S. Food and Drug Administration (FDA) found a link between taking Belviq and certain cancers. According to CNN, clinical trials showed that a large number of people who took Belviq to help with weight loss … [Read more...] about FDA Asks for Withdrawal of Belviq After Finding Cancer Link
Increased Risk of Cancer from Belviq Says FDA
WASHINGTON, D.C. — The weight loss medication Belviq and Belviq RX (lorcaserin HCL) could be linked to an increased chance of developing cancer, according to the latest warning from the U.S. Food and Drug Administration (FDA). The FDA made this announcement after reviewing the results concerning the safety of lorcaserin, which is the … [Read more...] about Increased Risk of Cancer from Belviq Says FDA
